Status:

RECRUITING

Evaluation of the Degradation of Renal Function Post Nephrectomy According to Retinal Vascularisation Parameters

Lead Sponsor:

Centre Hospitalier Universitaire Dijon

Conditions:

Nephrostomy

Retinal Vascularisation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Chronic kidney failure in the single remaining kidney is one of the dreaded complications of nephrectomy in patients operated on for cancer-related reasons (1). Indeed, chronic kidney disease (CKD) is...

Eligibility Criteria

Inclusion

  • Adult patient
  • Indication for total nephrectomy for kidney cancer decided with a multidisciplinary oncology consultation
  • Kidney scan images available
  • Patient affiliated to French national health insurance
  • Patient who has given oral consent

Exclusion

  • Pregnant woman
  • Ophthalmologic history (macular vascular or degenerative diseases, epiretinal membranes, glaucoma)
  • Cannot sit still for 60 minutes
  • Metastatic cancer
  • Single functional kidney before nephrectomy
  • Estimated Glomerular Filtration Flow Rate (CKD-EPI formula) less than 60 mL/min/1.73m2
  • Diabetes type 1 or type 2
  • Proteinuria at inclusion (or in the 3 months prior to inclusion) on sample with a protein/creatinuria ratio greater than 1g/g or over 24 hours greater than 1g/day
  • HIV, HCV or HBV positive serology
  • Patient subject to a measure of legal protection (guardianship, curatorship, etc.)
  • SECONDARY EXCLUSION CRITERIA
  • Patient with increased pressure during the measurement of the intraocular pressure before dilation
  • Patient with histological abnormalities suggestive of nephropathy (excluding nephroangiosclerosis) or ischemic parenchymal sequelae of renal vein thrombosis in the pathological analysis of the nephrectomy sample

Key Trial Info

Start Date :

March 18 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2025

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT04855123

Start Date

March 18 2021

End Date

March 1 2025

Last Update

May 6 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chu Dijon Bourgogne

Dijon, France, 21000